FDA 483 OBSERVATION · #65 OF 1,945 MOST-CITED

Calibration/Inspection/Checking not done

FDA cited this observation 378 times across 344 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.

BY PROGRAM AREA
Drugs378
BY FISCAL YEAR
FY202622
FY202533
FY202424
FY202323
FY202230
FY202118
FY202023
FY201947
FY201847
FY201752
FY201659

What this observation means, and how to comply

SPEQ's practitioner reading of this finding. The regulatory basis is a cited fact; the interpretation, compliance steps, and root causes are SPEQ synthesis — not an FDA classification of the citation.

21 CFR 820.72

21 CFR 820.72 (Inspection, measuring, and test equipment) is a Quality System Regulation section; since QMSR took effect on 2 February 2026 FDA inspects this as “Control of Monitoring and Measuring Equipment”: ISO 13485 clause 7.6 (CP 7382.850 Attachment A).

Inspection, measuring, and test equipment was not calibrated, inspected, or checked as required, so the equipment used to make quality decisions was not demonstrably accurate.

Why FDA writes it — Every acceptance decision depends on measurement equipment being accurate. Uncalibrated or unchecked equipment means the measurements behind release decisions are unreliable — and, when calibration lapses, all product accepted using that equipment since the last valid calibration is in question.

HOW TO COMPLY
  • Establish and maintain procedures to ensure equipment is routinely calibrated, inspected, checked, and maintained.
  • Calibrate against standards traceable to national or international standards (or document the basis where none exist).
  • Define and record calibration limits, and specify remedial action when equipment is found out of calibration — including assessing product accepted with it.
  • Keep calibration records identifying the equipment, date, and person.
WHY FIRMS GET CITED
  • Calibration schedules lapse, and out-of-calibration findings do not trigger an assessment of affected product.
  • Calibration performed but not traceable to recognized standards or not recorded.
PROFESSIONAL · REMEDIATION PLAYBOOK · SPEQ SYNTHESIS

How to close this finding — and stop it recurring

CHECKING ACCESS

Checking your access…

What this observation is associated with

Firms cited for this observation also appear in FDA compliance actions — warning letters, injunctions, or seizures — at 4.2× the rate of the average FDA-cited firm (32.6% vs 7.8%), across 344 FEI-matched firms.

This is an association, not causation, and reflects co-occurrence in FDA's records — not a claim that the observation caused or preceded the action.

CHECKING ACCESS

Checking your access…

How FDA worded it — real examples

Routine checking of equipment is not performed according to a written program designed to assure proper performance.

Hain-Celestial Canada, ULC · Mississauga · Drugs · 2026-09-17

Routine calibration of automatic and electronic equipment is not performed according to a written program designed to assure proper performance.

Coty US LLC · Sanford, North Carolina · Drugs · 2026-09-16

Routine calibration, inspection and checking of automatic, mechanical and electronic equipment is not performed according to a written program designed to assure proper performance.

CMIC Pharma Science Co., Ltd. · Ishikari · Drugs · 2026-09-03

Routine calibration of electronic equipment is not performed according to a written program designed to assure proper performance.

Neilmed Pharmaceuticals Inc · Santa Rosa, California · Drugs · 2026-07-22

Routine checking of automatic and mechanical equipment is not performed according to a written program designed to assure proper performance.

Aspen SA Sterile Operations (Pty) Ltd. · Port Elizabeth · Drugs · 2026-07-14

Routine checking of automatic equipment is not performed according to a written program designed to assure proper performance.

Meridian Medical Technologies, LLC a Subsidiary of Kindeva Drug Delivery, L.P. · Saint Louis, Missouri · Drugs · 2026-06-30

Related SPEQ references

Where to read the requirements behind this observation area on SPEQ. These are SPEQ's topic and audience pages — not an FDA classification of the citation.

Pharma industry →

Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →